Search - tctmd.com

Displaying 661 - 680 of 1339

Sort: Relevancy | Date

News Industry News

Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events

August 20, 2015

News Industry News

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

August 18, 2015

News Daily News

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

Todd Neale

August 17, 2015

News Daily News

国际性研究认为治疗差异与急性心梗患者死亡率存在关联

Yael L. Maxwell

August 14, 2015

News Daily News

Un Estudio Internacional Vincula las Variaciones de Tratamiento con la Mortalidad en el Manejo de IAM

Yael L. Maxwell

August 14, 2015

News Daily News

International Study Links Treatment Variations to Mortality in Acute MI

Yael L. Maxwell

August 14, 2015

News Daily News

分期 PCI 可能降低多支病变 STEMI 患者死亡率

L.A. McKeown

August 12, 2015

News Daily News

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

L.A. McKeown

August 12, 2015

News Daily News

Las PCI Programadas podrían Reducir la Mortalidad en Pacientes STEMI Con Enfermedad Multivaso

L.A. McKeown

August 12, 2015

News Daily News

急性心梗后进行心脏康复治疗这一实践仍未在年长患者中充分普及

Yael L. Maxwell

August 07, 2015

News Daily News

Un Estudio Identifica las Disparidades de Supervivencia Tras sufrir un IAM(1)

Yael L. Maxwell

August 07, 2015

News Daily News

Cardiac Rehab After Acute MI Still Underutilized in Older Patients

Yael L. Maxwell

August 07, 2015

News Daily News

年长房颤 PCI 患者在接受三联疗法时，其血栓状况未得到改善，且出血事件增加

August 04, 2015

News Daily News

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

August 04, 2015

News Daily News

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

August 04, 2015

News Daily News

在急性心肌梗死患者中，DES相对于BMS的早期生活质量优势在1年时消失

Yael L. Maxwell

July 31, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

Advertisement

Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

国际性研究认为治疗差异与急性心梗患者死亡率存在关联

Un Estudio Internacional Vincula las Variaciones de Tratamiento con la Mortalidad en el Manejo de IAM

International Study Links Treatment Variations to Mortality in Acute MI

分期 PCI 可能降低多支病变 STEMI 患者死亡率

Staged PCI May Lower Mortality in STEMI Patients With Multivessel Disease

Las PCI Programadas podrían Reducir la Mortalidad en Pacientes STEMI Con Enfermedad Multivaso

急性心梗后进行心脏康复治疗这一实践仍未在年长患者中充分普及

Un Estudio Identifica las Disparidades de Supervivencia Tras sufrir un IAM(1)

Cardiac Rehab After Acute MI Still Underutilized in Older Patients

年长房颤 PCI 患者在接受三联疗法时，其血栓状况未得到改善，且出血事件增加

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

在急性心肌梗死患者中，DES相对于BMS的早期生活质量优势在1年时消失

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content